Heart & Lung: The Journal of Acute and Critical Care
Volume 27, Issue 2 , Pages 146-148 , March 1998

Proteus penneri urosepsis in a patient with diabetes mellitus

  • Dorota K. Latuszynski, MD

      Affiliations

    • Microbiology Laboratory, the Pathology Department, and the Infectious Disease Division, Winthrop-University Hospital, Mineola, USA
    • State University of New York School of Medicine, Stony Brook, USA
    • ,
  • Paul Schoch, PhD

      Affiliations

    • Microbiology Laboratory, the Pathology Department, and the Infectious Disease Division, Winthrop-University Hospital, Mineola, USA
    • State University of New York School of Medicine, Stony Brook, USA
    • ,
  • Mohammad T. Qadir, MD

      Affiliations

    • Microbiology Laboratory, the Pathology Department, and the Infectious Disease Division, Winthrop-University Hospital, Mineola, USA
    • State University of New York School of Medicine, Stony Brook, USA
    • ,
  • Burke A. Cunha, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Burke A. Cunha, MD, Chief, Infectious Disease Division, Winthrop-University Hospital, Mineola, NY 11501.
    • Microbiology Laboratory, the Pathology Department, and the Infectious Disease Division, Winthrop-University Hospital, Mineola, USA
    • State University of New York School of Medicine, Stony Brook, USA

References 

  1. Hickman FW, Steigerwalt JJ, Farmer JJ, Brenner DJ. Identification of Proteus penneri sp. nov., formerly known as Proteus vulgaris indole negative or as Proteus vulgaris Biogroup I. I Clin Microbiol. 1982;15:1097–1102
  2. Na'Was TE, Mawajdeh S, Dababneh A, Al-Omari . In vitro activities of antimicrobial agents against Proteus species from clinical specimens. Br I Biomed Sci. 1994;51:95–99
  3. Sidorczyk Z, Zych K. Selected properties of the Proteus penneri sp. nov. from the American Collection. Med Dosw Mikrobiol. 1993;45:69–73
  4. Lukomski S, Pytlos M, Serwecinska L, Sidorczyk Z, Jaworski A. Analysis of antibiotic resistance determinants in Proteus penneri. Eur J Clin Microbiol Infect Dis. 1993;12:467–469
  5. Lukomski S, Muller B, Schmidt G. Extracellular hemolysin of Proteus penneri coded by chromosomal genes is similar to the alpha-hemolysin of E. coli. Int J Med. 1990;273:150–155
  6. Rozalski A, Kotelko K. Hemolytic activity and invasiveness in strains of Proteus penneri. J Clin Microbiol. 1987;26:1094–1096
  7. Lukomski S, Serwecinska L, Rozalski A, Dziadek J, Staczek P, Jaworski A. Cell-free and cell-bound hemolytic activities or Proteus penneri determined by different determinants. Can J Microbiol. 1991;37:419–424
  8. Müller HE. Occurrence and pathogenic role of Morganella Proteus-Providencia group bacteria in human feces. J Clin Microbiol. 1986;23:404–405
  9. Zych K, Swierzko A, Sidorczyk Z. Serological characterization of Proteus penneri species novum. Arch Immunol Ther Exp. 1992;40:92–98
  10. Krajden S, Fuksa M, Lizewski W, Barton L, Lee A. Proteus penneri isolated from the pus of a patient with epidural abscess. Kansenshogaku Zasshi. 1991;66:144–148
  11. Engler HD, Troy K, Bottone EJ. Bacteremia and subcutaneous abscess caused by Proteus penneri in a neutropenic host. J Clin Microbiol. 1990;28:1645–1646
  12. Kitch TT, Jacobs MR, Appelbaum PC. Evaluation of Rapid one system for identification of 379 strains in the family Enterobacteriaceae and oxidase-negative, gram-negative nonfermenters. J Clin Microbiol. 1994;32:931–934
  13. Krajden S, Fuksa M, Petrea C, Crisp LJ. Expanded clinical spectrum of infections caused by Proteus penneri. J Clin Microbiol. 1987;25:578–579
  14. Fuksa M, Krajden S, Lee A. Susceptibilities of 45 clinical isolates of Proteus penneri. Antimicrob Agents Chemother. 1984;26:419–420
  15. Miro E, Barthelemy M, Peduzzi J, Reynau A, Morand A, Prats G, et al.  Properties of a cephalosporinase produced by Proteus penneri which is inhibited by clavulanic acid. Pathol Biol. 1994;42:487–490
  16. Hawkey PM, Hawkey CA. Comparative in vitro activity of quinolone carboxylic acids against Proteae. J Antimicrob Chemother. 1984;14:485–489
  17. Reeves DS, Bywater MJ, Holt HA. The activity of cefpirome and ten other antimicrobial agents against 2858 clinical isolates collected from 20 centers. J Antimicrob Chemother. 1993;31:345–362
  18. Mobley HLT, Jones BD, Penner IL. Urease activity of Proteus penneri. J Clin Microbiol. 1987;25:2302–2305
  19. Picolomini R, Cellini L, Allocati N, Digiroamo A, Ravagnan G. Comparative in vitro susceptibilities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections. Antimicrob Agents Chemother. 1987;31:1644–1647
  20. Rozalski A, Bartoziejska B, Wykrota M, Serwecinska L, Lukomski S, Kotelko K. Characterization of hemolytic activity of Proteus penneri. Med Dosw Mikrobiol. 1993;45:79–83

PII: S0147-9563(98)90023-1

Heart & Lung: The Journal of Acute and Critical Care
Volume 27, Issue 2 , Pages 146-148 , March 1998

Article Tools